DanCann Pharma A/S to be inspected by the Danish Medicines Agency in Q4 2022: EU-GMP approval expected by the end of 2022
copenhagen denmark, November 8, 2022 – Duncan Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish cannabinoid-based company, expects to obtain EU-GMP approval for its Biotech Pharm1 (“BP1”)…